Regeneron Reports Third Quarter 2021 Financial and Operating Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. PLTR
3. VRTX
4. DOX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. CVI

Go back to Regeneron Reports Third Quarter 2021 Financial and Operating Results

Regeneron's (REGN) Antibody Cocktail Can Prevent Covid-19 Infection for 8 Months, Phase 3 Data Shows

November 8, 2021 8:30 AM EST

Shares of Regeneron Pharmaceuticals (NASDAQ: REGN) are up 1.5% in pre-open Monday after the company announced new phase 3 trial results for its antibody cocktail against COVID-19 infections.

Data showed that risks of getting COVID-19 were slashed by 82% for up to eight months in patients that... More

Regeneron (REGN) Tops Q3 EPS by $6.15

November 4, 2021 6:37 AM EDT

Regeneron (NASDAQ: REGN) reported Q3 EPS of $15.37, $6.15 better than the analyst estimate of $9.22. Revenue for the quarter came in at $3.45 billion versus the consensus estimate of $2.76 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.

... More